Ignite Creation Date:
2024-05-06 @ 6:21 PM
Last Modification Date:
2024-10-26 @ 2:46 PM
Study NCT ID:
NCT05634369
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2022-11-15
Brief Title:
A Multi-Institution Study of TGFβ Imprinted Ex Vivo Expanded Universal Donor NK Cell Infusions As Adoptive Immunotherapy in Combination with Gemcitabine and Docetaxel in Patients with Relapsed or Refractory Pediatric Bone and Soft Tissue
Sponsor:
Nationwide Childrens Hospital
Organization:
Nationwide Childrens Hospital
Organization Data
Organization:
Nationwide Childrens Hospital
Class:
OTHER
Study ID:
MCC21704
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nationwide Childrens Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Pediatric Cancer Foundation | OTHER |